Retatrutide Does Not Cause Postural Headaches
Based on available evidence, retatrutide is not associated with postural (orthostatic) headaches. The most common adverse events with retatrutide are gastrointestinal in nature, not neurological or postural symptoms.
Evidence from Clinical Trials
The largest and most recent phase 3 trial (TRIUMPH-2) involving 1,152 adults with obesity and type 2 diabetes found that the most frequently reported adverse events with retatrutide were 1:
Gastrointestinal symptoms (most common):
- Diarrhea: 27-34% with retatrutide vs 13% with placebo
- Nausea: 14-28% with retatrutide vs 8% with placebo
- Vomiting and constipation also reported
Other adverse events (less common):
- Hypotension: 1-6% with retatrutide vs <1% with placebo
- Dysesthesia: 4-7% with retatrutide vs 1% with placebo
Notably, headaches—postural or otherwise—were not listed among the common or significant adverse events in this comprehensive trial 1.
Understanding Postural Headaches
Postural (orthostatic) headaches have a very specific clinical presentation 2:
- Absent or mild (1-3/10) when lying flat or upon waking
- Onset within 2 hours of becoming upright
50% improvement within 2 hours of lying flat
- Consistent timing pattern
These headaches are typically caused by cerebrospinal fluid (CSF) leakage or intracranial hypotension 3, 2, not by medications like retatrutide.
Clinical Context
While retatrutide can cause hypotension in 1-6% of patients 1, this is distinct from postural headaches. Hypotension itself might theoretically cause lightheadedness when standing, but this is not the same as the classic orthostatic headache syndrome.
If a patient on retatrutide develops postural headaches, investigate alternative causes 2:
- Spontaneous intracranial hypotension (CSF leak)
- Postural tachycardia syndrome (PoTS)
- Orthostatic hypotension from other causes
- Recent dural puncture procedures
- Cervicogenic headache
- Migraine
Bottom Line
Retatrutide's adverse event profile is dominated by gastrointestinal symptoms (nausea, diarrhea, vomiting) that occur due to GLP-1 receptor agonism and delayed gastric emptying 1, 4. Postural headaches are not a recognized adverse effect of this medication. If postural headaches develop in a patient taking retatrutide, pursue standard diagnostic evaluation for orthostatic headache etiologies rather than attributing them to the medication.